Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Canada

 

Workplace Options bought out by Canadian TELUS Health

TELUS Health, a health and wellbeing provider headquartered in Vancouver (operating under parent company TELUS Corporation), has announced the acquisition of Workplace Options, the world’s largest privately owned and independent global provider of integrated employee wellbeing solutions, supported by a strategic partnership with GTCR, a private equity investor with expertise in healthcare. 

Brookfield Asset Management takeover of Grifols continues to progress with new debt financing move

The anticipated Brookfield Asset Management takeover of Catalonia’s Grifols has gathered fresh momentum, with the firm reportedly in talks with banks to secure approximately €9.5 billion in debt financing towards the deal, according to Bloomberg sources.  The Canadian investment firm is exploring the acquisition in partnership with the Grifols family, who hold a ~30% stake […]

Addressing healthcare workforce inefficiency through AI and 3d indoor mapping – a conversation with Connie Moser of Navenio

Modern hospitals are incredibly complex, regularly chaotic, and often inefficient environments, despite efficiency and proper task sequencing being vital to delivering high-quality medical care and positive patient experiences. Workforce issues are beginning to bite harder across both public and private provider systems, driven by a growing deficit in medical professionals serving an expanding patient population. […]

Interview: Kelly Hudson, Chief Strategy Officer, Lilli

The opportunities afforded by advances in technology to assist with caring for the elderly are huge, but much of the focus remains on reactive tools. HBI speaks to Kelly Hudson, chief strategy officer of UK remote technology company Lilli to hear why the focus needs to be more on proactive solutions.

Eugin sells for €500m

Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.

Interview: Jim Kean, CEO, Molecular You

HBI speaks to Jim Kean, CEO of Molecular You, a North American start-up that does tests which analyse patients' proteins and metabolites (small molecules produced during metabolism) to predict what diseases they are at risk of having. Kean tells us that through the use of hundreds of biomarkers and with the help of AI, they are able to achieve a 98% predictive accuracy for certain conditions.

Find Us